TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Prostatype Genomics AB
Closing information (x1000 DKK)
Closing information | 2023/12 (consolidated) | 2022/12 | 2021/12 |
Turnover |
911
|
456
|
7 |
Financial expenses |
1,472
|
265
|
59 |
Earnings before taxes |
-27,831
|
-19,437
|
-11,365 |
EBITDA |
-25,102
|
-17,899
|
-11,241 |
Total assets |
33,061
|
20,682
|
29,233 |
Current assets |
17,403
|
9,468
|
15,695 |
Current liabilities |
16,444
|
2,895
|
2,494 |
Equity capital |
16,572
|
17,475
|
26,108 |
- share capital |
4,815
|
917
|
658 |
Employees (average) |
7
|
6
|
5 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 | 2021/12 |
Solvency |
50.1%
|
84.5%
|
89.3% |
Turnover per employee |
130
|
76
|
1 |
Profit as a percentage of turnover |
-3055.0%
|
-4262.5%
|
-162357.1% |
Return on assets (ROA) |
-79.7%
|
-92.7%
|
-38.7% |
Current ratio |
105.8%
|
327.0%
|
629.3% |
Return on equity (ROE) |
-167.9%
|
-111.2%
|
-43.5% |
Change turnover | |||
Change turnover % |
6730%
|
-99% | |
Chg. No. of employees | |||
Chg. No. of employees % |
20%
|
0% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.